Sunshine Hospital

Saint Albans, Victoria 3021

3 studies enrolling now · 7 studies all time

What they study most

Advanced Breast Cancer, Advanced Lung Cancer, Advanced Solid Tumor, Breast Cancer, Cutaneous Melanoma, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, IgA Nephropathy, Immunoglobulin A Nephropathy, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Metastatic Breast Cancer, Metastatic Cancer

Studies at this site

• Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer — Recruiting now
• Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer — Recruiting now
• A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer — Recruiting now
• Atrasentan in Patients With IgA Nephropathy — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] — Completed
• Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma — Completed